AIA AND TOTTENHAM HOTSPUR FOOTBALL CLUB EXTEND PARTNERSHIP THROUGH TO 2032

AIA Group Limited ("AIA" or the "Group") today announces that it will extend its successful association with Tottenham ...
National Hockey League

PREVIEW: Blackhawks Face Sharks in 2024-25 Home Opener Showdown

Chicago looks to extend streak against Sharks with multiple players debuting at home ...
TMCnet

Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session ...

Apptio Unveils Next-Generation FinOps Solutions Designed to Redefine How Cloud Leaders Manage and Optimize Investments in the AI Era

Apptio, an IBM company (NYSE: IBM), today unveiled next-generation FinOps solutions from IBM Cloudability and IBM Kubecost ...
Taiwan News

Cellectis to Present a Development Update for eti-cel at ASH 2025

Preliminary data recently shared for eti-cel (UCART20x22) show an 86% ORR and a 57% CR rate (n=7), underscoring its potential to improve outcomes in r/r NHL; Preclinical data demo ...
IGN Middle East

Xbox Console Exclusive Stalker 2 Is Set to Leave Game Pass in November and Some Subscribers Do Not Like That One Bit

Microsoft has confirmed the next batch of games set to leave Xbox Game Pass, and one in particular has caused a degree of ...
Taiwan News

Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with ...

86% ORR, 63% CR rate, 53% PFS at 12 months in patients who received vispa-cel with an optimized profile (N=35) Vispa-cel is generally well-tolerated, allowing for administration in the outpatient ...